{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T12:23:51Z","timestamp":1764937431337,"version":"3.38.0"},"reference-count":0,"publisher":"JLE","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,1]]},"DOI":"10.1684\/vir.2022.0927","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T14:00:09Z","timestamp":1657116009000},"page":"228-239","source":"Crossref","is-referenced-by-count":1,"title":["Traitement de l\u2019h\u00e9patite B chronique par t\u00e9nofovir : aspects virologiques et pharmacologiques"],"prefix":"10.1684","volume":"26","member":"18929","container-title":["Virologie"],"original-title":[],"link":[{"URL":"https:\/\/www.jle.com\/10.1684\/vir.2022.0927","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:09:33Z","timestamp":1741190973000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jle.com\/10.1684\/vir.2022.0927"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[2022,5,1]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,5,1]]}},"URL":"https:\/\/doi.org\/10.1684\/vir.2022.0927","relation":{},"ISSN":["1267-8694"],"issn-type":[{"type":"print","value":"1267-8694"}],"subject":[],"published":{"date-parts":[[2022,5,1]]}}}